ICO
Closing Date:

Novel Approaches for the Delivery of Viable and Healthy Cells for Cell Therapy Treatment

Novo Nordisk is seeking novel cell delivery solutions to improve cell therapy treatments in humans. Specifically, the team is interested in device, biomaterial and formulation approaches to improve efficacy in Type 1 Diabetes, Chronic Heart failure and Parkinson’s Disease.

Approaches of Interest:

  • Biomaterial or formulation approaches for the preparation and administration of viable and healthy cells at point of delivery (i.e. recovery from cryopreservation, resuspension and delivery).
    • Key challenges include limiting cell stress (shear, temperature and...

Opportunity types being sought:

  • Biotech Asset

  • Spinout Company

  • Research Project

  • Centre of Excellence

  • Academic Researcher

  • Technology

To see the full details and submit your response please register now.

Benefits of registration:

  • Receive updates on the latest industry calls
  • Quickly and easily respond to calls via your dashboard
  • Build your academic profile

Opportunity types being sought:

  • Biotech Asset

  • Spinout Company

  • Research Project

  • Centre of Excellence

  • Academic Researcher

  • Technology

An online matchmaking platform for university-industry collaboration. Learn More

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.